evo真人视讯

Thai business tycoon Npairoj Piempongsant visits Shenzhen Cell Valley

Date:04-15  Hits:  Belong to:Corporate News

On April 12, Mr.Npairoj Piempongsant, Chairman of Thailand's Empire Asia Holding Co., Ltd. and founder of STP-AI, visited Shenzhen Cell Valley for an exchange. He was warmly received by Chairman Shi Yuanyuan, Chief Scientist Wang Jianxun, and Deputy General Manager Tang Xiaomeng.

First, Chairman Shi Yuanyuan accompanied Mr.Npairoj on a tour of Cell Valley's smart exhibition hall, production workshop, R&D and quality inspection laboratories. He introduced Cell Valley's strategic layout in the field of cell and gene therapy, the founding team, unique advantages in core technologies such as retroviral vector preparation and cell product manufacturing processes, as well as rigorous quality management with full-process traceability. Mr.Npairoj expressed high appreciation for Cell Valley's current development prospects and technological advantages.

During the visit and exchange, Chairman Shi Yuanyuan provided a detailed introduction to the technological breakthroughs and clinical application progress of Shenzhen Cell Valley. Currently, dozens of patients with advanced cancer have received CAR-T cell therapy prepared by Shenzhen Cell Valley, targeting anti-BCMA, CD38, CD7, CD19, and dual-target CD19/CD22, all of which have achieved favorable responses. Additionally, Shenzhen Cell Valley has overcome the global challenges in preparing CAR-NK and CAR-γδT cells, offering new therapeutic options for solid tumor treatment.

Mr.Npairoj stated that Thailand has long been renowned for its international medical tourism, with the capital Bangkok consistently ranking as the world's top destination for international visitors. Currently, Thailand is positioning itself as a global hub for cancer treatment. He extended a warm welcome to Shenzhen Cell Valley for a visit to Thailand and sincerely invited the Shenzhen Cell Valley team to establish an R&D center in Bangkok. Chairman Shi Yuanyuan expressed that the possibility of expanding operations in Thailand would be actively considered.

Mr.Npairoj is a renowned Thai businessman who served as Chief of Staff to the Prime Minister's Office in Thailand for a long time during the 1990s. In 2005, his conglomerate acquired the famous Premier League team Manchester City, and Mr.Npairoj led the transfer of Chinese player Sun Jihai to Manchester City. His multiple enterprises have achieved outstanding accomplishments in privatized infrastructure, industrial and commercial real estate development, traditional and alternative energy, telecommunications, sports management and promotion (mainly British professional football), as well as general trade and investment.

take a group photo to mark the occasion


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@rodael.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Bottom Navigation
Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software